New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 1, 2013
09:00 EDTALKSAlkermes falls 7%
Alkermes is down 7%, or $1.61, to $21.44
News For ALKS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 26, 2015
07:52 EDTALKSAlkermes schizophrenia drug profile looks interesting, says Cowen
Subscribe for More Information
June 24, 2015
07:48 EDTALKSAlkermes data support ALKS 3831 potential, says Credit Suisse
Subscribe for More Information
05:51 EDTALKSAlkermes physician call on ALKS 3831 encouraging, says UBS
Subscribe for More Information
June 19, 2015
10:31 EDTALKSAlkermes to host conference call
Conference call to discuss the six-month data of ALKS 3831 for the treatment of schizophrenia will be held on June 23 at 8 am. Webcast Link
June 17, 2015
10:52 EDTALKSAlkermes lower after CEO tells WSJ not interested in selling
Subscribe for More Information
10:32 EDTALKSAlkermes CEO says not interested in selling company, WSJ reports
Subscribe for More Information
June 16, 2015
11:16 EDTALKSAlkermes says company doesn't comment on rumors, Feuerstein reports
Strength in shares of Alkermes (ALKS) this morning is being attributed by traders to speculation of a takeover. A company spokesperson reportedly told TheStreet's Adam Feuerstein that the company does not comment on rumors or speculation. Shares of Alkermes are up $4.70, or about 8%, to $63.29 in late morning trading. Reference Link
10:07 EDTALKSAlkermes spike attributed to takeover speculation
The spike higher in shares of Alkermes (ALKS) is being attributed by traders to speculation of a takeover. Shares jumped 6% to $61.89 in morning trading. The Ireland based drugmaker focuses on treatments of central nervous system disorders, such as addiction, schizophrenia and depression. The speculative chatter has Merck (MRK) as a potential acquirer of Alkermes. The company’s June 60 and 65 calls are actively trading, according to The Fly's options specialist.
10:06 EDTALKSHigh option volume stocks
Subscribe for More Information
10:01 EDTALKSAlkermes calls active
Alkermes June 60 and 65 calls are active on total call volume of 800 contracts (0 puts) on renewed takeover chatter. June call option implied volatility is at 75, July is at 46, August is at 45; compared to its 52-week range of 33 to 59. Active call volume suggests traders taking positions for large price movement.
09:55 EDTALKSRumor: Alkermes shares active on renewed takeover speculation
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use